Studies on the Intestinal Absorption Characteristics of Sulfasalazine, a Breast Cancer Resistance Protein (BCRP) Substrate

被引:14
作者
Tomaru, Atsuko [1 ]
Morimoto, Nozomi [1 ]
Morishita, Mariko [1 ]
Takayama, Kozo [1 ]
Fujita, Takuya [2 ]
Maeda, Kazuya [3 ]
Kusuhara, Hiroyuki [3 ]
Sugiyama, Yuichi [3 ]
机构
[1] Hoshi Univ, Dept Pharmaceut, Tokyo 1428501, Japan
[2] Ritsumeikan Univ, Coll Pharmaceut Sci, Shiga, Japan
[3] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Tokyo, Japan
关键词
sulfasalazine; BCRP; intestinal absorption; everted sac; transporter; RHEUMATOID-ARTHRITIS; P-GLYCOPROTEIN; CLINICAL PHARMACOKINETICS; 5-AMINOSALICYLIC ACID; ABCG2; BCRP; EXPRESSION; SULPHASALAZINE; POLYMORPHISMS; PERMEABILITY; TRANSPORTER;
D O I
10.2133/dmpk.DMPK-12-NT-024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Oral sulfasalazine (SASP) is now used clinically as a probe substrate of a breast cancer resistance protein (BCRP) activity; however the intestinal absorption characteristics of SASP are not well understood. The purpose of this study was to clarify the characteristics of SASP transport in the mouse intestine. The everted ileum was incubated with SASP in the absence or presence of the Bcrp inhibitor Ko134. The steady-state intestinal absorptive clearance was 0.14 mu L/min/cm in the absence of Ko134 and increased by 4.8-fold in the presence of Ko134. These results indicate that Bcrp mediates the efflux of SASP in the intestine. The absorptive clearance of SASP did not change in a concentration-dependent manner in the range of 0.1 to 50 mu M in wild-type mice. By contrast, the absorptive clearance of SASP decreased significantly in a concentration-dependent manner in the presence of Ko134. Similar results were obtained in Bcrp(-/-) mice. These results suggest the possible involvement of some influx transporters in the intestinal absorption of SASP. In conclusion, both the influx and efflux transporters are involved in the intestinal absorption of SASP, which would explain why the absorptive clearance did not appear to change at various SASP concentrations in wild-type mice.
引用
收藏
页码:71 / 74
页数:4
相关论文
共 24 条
[1]  
Bird HA, 1995, BRIT J RHEUMATOL, V34, P16
[2]   MRP2 mediated drug-drug interaction: Indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting [J].
Dahan, Arik ;
Amidon, Gordon L. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 386 (1-2) :216-220
[3]   Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting [J].
Dahan, Arik ;
Amidon, Gordon L. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 297 (02) :G371-G377
[4]   CLINICAL PHARMACOKINETICS OF SULFASALAZINE [J].
DAS, KM ;
DUBIN, R .
CLINICAL PHARMACOKINETICS, 1976, 1 (06) :406-425
[5]   Regional expression and activity of breast cancer resistance protein (Bcrp/Abcg2) in mouse intestine: Overlapping distribution with sulfotransferases [J].
Enokizono, Junichi ;
Kusuhara, Hiroyuki ;
Sugiyama, Yuichi .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (06) :922-928
[6]   AZO REDUCTION OF SULPHASALAZINE IN HEALTHY-VOLUNTEERS [J].
HOUSTON, JB ;
DAY, J ;
WALKER, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :395-398
[7]   Kinetic Characterization of Sulfasalazine Transport by Human ATP-Binding Cassette G2 [J].
Jani, Marton ;
Szabo, Pal ;
Kis, Emese ;
Molnar, Eva ;
Glavinas, Hristos ;
Krajcsi, Peter .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2009, 32 (03) :497-499
[9]   Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP [J].
Kusuhara, Hiroyuki ;
Furuie, Hidetoshi ;
Inano, Akihiro ;
Sunagawa, Akihiro ;
Yamada, Saiko ;
Wu, Chunyong ;
Fukizawa, Shinya ;
Morimoto, Nozomi ;
Ieiri, Ichiro ;
Morishita, Mariko ;
Sumita, Kiminobu ;
Mayahara, Hiroshi ;
Fujita, Takuya ;
Maeda, Kazuya ;
Sugiyama, Yuichi .
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (06) :1793-1803
[10]   Closing the gaps: A full scan of the intestinal expression of P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats [J].
MacLean, Caroline ;
Moenning, Ulla ;
Reichel, Andreas ;
Fricker, Gert .
DRUG METABOLISM AND DISPOSITION, 2008, 36 (07) :1249-1254